Mass Spectrometry as a Quantitative Tool for SpCas9 sgRNA Quality Control

Mass spectrometry (MS) has long been used for quality control of oligonucleotide therapeutics, including single-guide RNAs (sgRNAs) for clustered regularly interspaced short palindromic repeats techniques. However, the application of MS is limited to qualitative assays in most cases. Here, we showed that electrospray-ionization quadrupole time-of-flight MS (ESI-QTOF-MS) assays can be quantitative for chemical species found in sgRNA samples. More specifically, using a 100-nt SpCas9 sgRNA as the example, we estimated that the limits of quantification for length variants in the range of N - 4 to N + 4 (i.e., 96-104 nucleotides) were equal to or lower than 1%. Our study highlighted the potential of ESI-QTOF in its application as a quality control method for sgRNA molecules.

Authors

Institutions

Publication Details

Journal
Nucleic Acid Therapeutics
Published
2024-08-23
DOI
https://doi.org/10.1089/nat.2024.0043
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mass Spectrometry as a Quantitative Tool for SpCas9 sgRNA Quality Control

Puzhou Wang, Juan Daniel Avila
Nucleic Acid Therapeutics
CRISPR and Genetic Engineering
article

Mass Spectrometry as a Quantitative Tool for SpCas9 sgRNA Quality Control

Puzhou Wang, Juan Daniel Avila
article en

Abstract

Mass spectrometry (MS) has long been used for quality control of oligonucleotide therapeutics, including single-guide RNAs (sgRNAs) for clustered regularly interspaced short palindromic repeats techniques. However, the application of MS is limited to qualitative assays in most cases. Here, we showed that electrospray-ionization quadrupole time-of-flight MS (ESI-QTOF-MS) assays can be quantitative for chemical species found in sgRNA samples. More specifically, using a 100-nt SpCas9 sgRNA as the example, we estimated that the limits of quantification for length variants in the range of N - 4 to N + 4 (i.e., 96-104 nucleotides) were equal to or lower than 1%. Our study highlighted the potential of ESI-QTOF in its application as a quality control method for sgRNA molecules.

Nucleic Acid TherapeuticsVol. 34(6)
Synthego (United States) (US)
Openalex Percentile: Top 88%
CRISPR and Genetic Engineering
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Mass Spectrometry as a Quantitative Tool for SpCas9 sgRNA Quality Control — Puzhou Wang, Juan Daniel Avila · Nucleic Acid Therapeutics (2024) | TGRS Research Map | TGRS